Mylan Announces Fiscal 2003 GuidancePITTSBURGH, Mar 5, 2002 (BUSINESS WIRE) -- Mylan Laboratories Inc. (NYSE:MYL) today is pleased to announce its fiscal 2003 guidance of $2.05 - $2.09.

As previously announced, Mylan will host a conference call and Webcast today, at 10:00 AM ET. The dial-in-number to access this call is (913) 981-4900.

Because these statements are forward-looking, our actual results may differ materially from the results projected in those statements. We encourage you to read "Forward Looking Statements" in Item 7 of our annual report on Form10-K for the year ended March 31, 2001 for a discussion of the factors that could cause a material difference in our results. You may access this report through the web site of the Securities and Exchange Commission at www.sec.gov or through various independent Edgar access sites.

Mylan Laboratories Inc. is a leading pharmaceutical company that develops, manufactures and markets generic and proprietary prescription pharmaceutical products. The Company markets an extensive line of generic products through three business units, Mylan Pharmaceuticals Inc., Mylan Technologies Inc., and UDL Laboratories, Inc. and branded products through its Bertek Pharmaceuticals Inc. subsidiary. For more information, visit www.mylan.com.

CONTACT:          Mylan Laboratories Inc., Pittsburgh
                  Patricia Sunseri, 412/232-0100

URL:              http://www.businesswire.com
Today's News On The Net - Business Wire's full file on the Internet
with Hyperlinks to your home page.

Copyright (C) 2002 Business Wire.  All rights reserved.